Cystagon (cysteamine) Disease Interactions
There are 2 disease interactions with Cystagon (cysteamine):
Cysteamine (Includes Cystagon) ↔ Alcoholism
Severe Potential Hazard, Moderate plausibility
Applies to: Alcoholism
The use of alcohol may increase the rate of cysteamine release and/or adversely alter the pharmacokinetic properties, as well as the effectiveness and safety. It is recommended to avoid the consumption of alcoholic beverages during treatment with cysteamine.
Cysteamine (Includes Cystagon) ↔ Liver Disease
Moderate Potential Hazard, Moderate plausibility
Applies to: Liver Disease
The use of cysteamine has been associated with development of hepatic coma in patients with overt hepatic damage. Therapy with cysteamine should be administered cautiously in patients with liver disease.
- "Product Information. Cystagon (cysteamine)." Mylan Pharmaceuticals, Morgantown, WV.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.